SAN FRANCISCO -- Providing long-acting (LA) antiretroviral therapy (ART) to breastfeeding women with HIV who face adherence ...

Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.

The project has four roving clinics that influencers are contracted to visit to brand HIV prevention as hip and ‘cool’ ...

Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

When it came to innovations in biotech, there was a clear winner: lenacapavir, a drug that was found to prevent HIV infections in 100% of the women and girls who received it in a clinical trial.

The results of a groundbreaking trial carried out in Durban to find a cure for HIV are showing promise, scientists say.

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...